169 related articles for article (PubMed ID: 33080322)
1. The Nrf2 in the pathophysiology of the intestine: Molecular mechanisms and therapeutic implications for inflammatory bowel diseases.
Piotrowska M; Swierczynski M; Fichna J; Piechota-Polanczyk A
Pharmacol Res; 2021 Jan; 163():105243. PubMed ID: 33080322
[TBL] [Abstract][Full Text] [Related]
2. Role of Oxidative Stress and Nrf2/KEAP1 Signaling in Colorectal Cancer: Mechanisms and Therapeutic Perspectives with Phytochemicals.
Lee DY; Song MY; Kim EH
Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34067204
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal redox homeostasis in ageing.
Homolak J
Biogerontology; 2023 Oct; 24(5):741-752. PubMed ID: 37436501
[TBL] [Abstract][Full Text] [Related]
4. Anti-Viral Potential and Modulation of Nrf2 by Curcumin: Pharmacological Implications.
Rahban M; Habibi-Rezaei M; Mazaheri M; Saso L; Moosavi-Movahedi AA
Antioxidants (Basel); 2020 Dec; 9(12):. PubMed ID: 33291560
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of increasing omega-3, omega-6 and total polyunsaturated fats on inflammatory bowel disease and markers of inflammation: a systematic review and meta-analysis of randomized controlled trials.
Ajabnoor SM; Thorpe G; Abdelhamid A; Hooper L
Eur J Nutr; 2021 Aug; 60(5):2293-2316. PubMed ID: 33084958
[TBL] [Abstract][Full Text] [Related]
6. Thiopurine Drugs in the Treatment of Ulcerative Colitis: Identification of a Novel Deleterious Mutation in TPMT.
Harmand PO; Solassol J
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33081236
[TBL] [Abstract][Full Text] [Related]
7. Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases.
Barnes EL; Loftus EV; Kappelman MD
Gastroenterology; 2021 Feb; 160(3):677-689. PubMed ID: 33098884
[TBL] [Abstract][Full Text] [Related]
8. Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease.
Almradi A; Hanzel J; Sedano R; Parker CE; Feagan BG; Ma C; Jairath V
BioDrugs; 2020 Dec; 34(6):713-721. PubMed ID: 33105016
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy in women with inflammatory bowel disease: a French nationwide study 2010-2018.
Meyer A; Drouin J; Weill A; Carbonnel F; Dray-Spira R
Aliment Pharmacol Ther; 2020 Nov; 52(9):1480-1490. PubMed ID: 33095502
[TBL] [Abstract][Full Text] [Related]
10. The Gut Microbiome and the Triple Environmental Hit Concept of Inflammatory Bowel Disease Pathogenesis.
Kellermayer R; Zilbauer M
J Pediatr Gastroenterol Nutr; 2020 Nov; 71(5):589-595. PubMed ID: 33093364
[TBL] [Abstract][Full Text] [Related]
11. Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy.
Panaccione R; Danese S; Sandborn WJ; O'Brien CD; Zhou Y; Zhang H; Adedokun OJ; Tikhonov I; Targan S; Abreu MT; Hisamatsu T; Scherl EJ; Leong RW; Rowbotham DS; Arasaradnam RP; Sands BE; Marano C
Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1658-1675. PubMed ID: 33086438
[TBL] [Abstract][Full Text] [Related]
12. Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis.
Liu C; Li Y; Chen Y; Huang S; Wang X; Luo S; Su Y; Zhou L; Luo X
Mediators Inflamm; 2020; 2020():5918587. PubMed ID: 33082710
[TBL] [Abstract][Full Text] [Related]
13. Real-life experience with 4 years of golimumab persistence in ulcerative colitis patients.
Iborra M; García-Morales N; Rubio S; Bertoletti F; Calvo M; Taxonera C; Boscá-Watts MM; Sierra M; Mancenido N; Beltrán B; Nantes Castillejo Ó; García-Planella E; Vera I; Alba C; Martí-Aguado D; Ballester MP; Cano-Sanz N; Pajares-Villarroya R; Cerrillo E; Cañada A; Nos P
Sci Rep; 2020 Oct; 10(1):17774. PubMed ID: 33082359
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the Crosstalk between NRF2 Signaling and Metabolic Processes in Cancer.
DeBlasi JM; DeNicola GM
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33080927
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of fibrosis and stricture formation in Crohn's disease.
Alfredsson J; Wick MJ
Scand J Immunol; 2020 Dec; 92(6):e12990. PubMed ID: 33119150
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis.
Tang B; Zhu J; Zhang B; Wu F; Wang Y; Weng Q; Fang S; Zheng L; Yang Y; Qiu R; Chen M; Xu M; Zhao Z; Ji J
Front Immunol; 2020; 11():592084. PubMed ID: 33240279
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of tryptophan-catabolizing Lactobacillus plantarum KLDS 1.0386 against dextran sodium sulfate-induced colitis in mice.
Shi J; Du P; Xie Q; Wang N; Li H; Smith EE; Li C; Liu F; Huo G; Li B
Food Funct; 2020 Dec; 11(12):10736-10747. PubMed ID: 33231244
[TBL] [Abstract][Full Text] [Related]
18. Alcohol decreases intestinal ratio of
Kuprys PV; Cannon AR; Shieh J; Iftekhar N; Park SK; Eberhardt JM; Ding X; Choudhry MA
Gut Microbes; 2020 Nov; 12(1):1-16. PubMed ID: 33180663
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanisms and clinical trial endpoints in intestinal fibrosis.
Wang J; Lin S; Brown JM; van Wagoner D; Fiocchi C; Rieder F
Immunol Rev; 2021 Jul; 302(1):211-227. PubMed ID: 33993489
[TBL] [Abstract][Full Text] [Related]
20. How autophagy controls the intestinal epithelial barrier.
Foerster EG; Mukherjee T; Cabral-Fernandes L; Rocha JDB; Girardin SE; Philpott DJ
Autophagy; 2022 Jan; 18(1):86-103. PubMed ID: 33906557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
